← back to search

Xiaojian Han

Nanchang University · CN
🔎 Find collaborators in Infectious Diseases · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Infectious Diseases · Oncology
Research interest
Research interests include Monoclonal antibody, Antibody, Epitope, T cell, Virology, and Apoptosis.
h-index
citations
511
works
25
NIH funding
primary concept
email

Recent publications

Association of blood urea nitrogen with all-cause and cardiovascular mortality in hyperlipidemia: NHANES 1999–2018
Lipids in Health and Disease 2024cited by 22position: lastdoi
Targeted inhibition of branched-chain amino acid metabolism drives apoptosis of glioblastoma by facilitating ubiquitin degradation of Mfn2 and oxidative stress
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024cited by 16position: middledoi
Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron
JCI Insight 2024cited by 4position: middledoi
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium
Cell Reports 2023cited by 41position: middledoi
An efficient new adaptive variational mode decomposition algorithm for extracting adventitious lung sounds
Biomedical Signal Processing and Control 2023cited by 12position: middledoi
Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants
Genes & Diseases 2021cited by 54position: middledoi
IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities
Frontiers in Molecular Biosciences 2021cited by 53position: middledoi
Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
Nature Communications 2021cited by 50position: middledoi
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
Frontiers in Immunology 2021cited by 33position: firstdoi
p38 inhibition enhances TCR-T cell function and antagonizes the immunosuppressive activity of TGF-β
International Immunopharmacology 2021cited by 16position: middledoi
TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy
Frontiers in Molecular Biosciences 2021cited by 12position: middledoi
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 4position: middledoi
TRAIL-R1-targeted chimeric antigen receptor T cells exhibit dual antitumor effects
2021cited by 1position: middledoi
A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBD
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 12position: firstdoi
Identification of Cross-Reactive CD8 <sup>+</sup> T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 8position: middledoi
A key linear epitope for a potent neutralizing antibody to SARS-CoV-2 S-RBD
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 7position: middledoi
Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies
Genes & Diseases 2020cited by 6position: middledoi
A rapid and efficient screening system for neutralizing antibodies and its application for SARS-CoV-2
Research Square 2020cited by 2position: firstdoi
Analysis of the clinical significance of DCLK1&lt;sup&gt;+&lt;/sup&gt; colorectal cancer using novel monoclonal antibodies against DCLK1
OncoTargets and Therapy 2018cited by 13position: middledoi
Combination of tumor necrosis factor related apoptosis-inducing ligand with its type-I receptor-specific monoclonal antibody enhanced anti-tumor effects in vitro and in vivo
Int J Immunol 2018cited by 0position: lastdoi
Amyloid β-42 induces neuronal apoptosis by targeting mitochondria
Molecular Medicine Reports 2017cited by 137position: firstdoi
Identification of Novel Epitopes with Agonistic Activity for the Development of Tumor Immunotherapy Targeting TRAIL-R1
Journal of Cancer 2017cited by 2position: middledoi
Fully human monoclonal antibodies to TRAIL-R1 enhance TRAIL-induced apoptosis via activation of caspase-8 pathway
Biochemical and Biophysical Research Communications 2016cited by 10position: middledoi
Immunotherapy based on chimeric antigen Receptor T cell for solid Cancers
Int J Immunol 2016cited by 0position: firstdoi
Establishment of a high efficient expression system of a novol human monoclonal antibody against tumour necrosis factor-related apoptosis-inducing ligand receptor and its functional characteristics
Int J Immunol 2015cited by 0position: middledoi
Establishment of activation and differentiation of memory B cells into antigen-specific secreting cells from peripheral blood mononuclear cells in vitro
Int J Immunol 2015cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Aishun Jin · Harbin Medical University10 papers (2016–2021)Meiying Shen · Harbin Medical University9 papers (2016–2021)Da Pang · First People's Hospital of Foshan7 papers (2016–2021)Jingjing Huang · Nanjing University of Chinese Medicine7 papers (2016–2021)Wang Wang · Nanchang University6 papers (2020–2021)Li Du · Children's Hospital of Zhejiang University5 papers (2020–2021)Chao Hu · Suizhou Central Hospital4 papers (2020–2021)Shenglong Li · Nantong University4 papers (2020–2021) · 4 papers (2020–2021) · 3 papers (2016–2018)Tingting Li · Xiamen University3 papers (2020–2021)Jianwei Wang · Chengdu University of Traditional Chinese Medicine3 papers (2020–2021)Yingming Wang · Anhui Medical University3 papers (2020–2021)Yaying Li · Shandong University of Traditional Chinese Medicine3 papers (2016–2018)Kun Tao · Virginia Commonwealth University3 papers (2020–2021)Xin Sun · Nantong University3 papers (2016–2018) · 3 papers (2016–2018) · 3 papers (2016–2018) · 3 papers (2020–2021)Xin-Hui Qu · Nanchang University2 papers (2024–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Infectious Diseases · Oncology →